logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11 Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (ii) New outpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates12.526.344.750.649.649.248.446.4358485475
Cocaine8.022.031.932.734.132.430.824.2263895509
Stimulants2.85.64.84.03.43.92.51.751241315
Hypnotics and sedatives1.81.11.72.94.67.010.118.82386658
Hallucinogens0.20.50.50.40.30.40.30.2463221
Volatile substances0.61.00.10.10.10.20.10.1644198
Cannabis 72.442.315.48.06.45.25.03.93881214521
Other substances 1.71.31.01.31.61.82.84.81547284
Total1722151000219869684536930621571132011121328181
 

Notes:

Countries reporting data: BE, BG, CZ, DK, DE,EE, IE, EL, ES, FR, IT, CY, LV, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, UK, HR

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-106 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI — outpatient treatment centres.

Page last updated: Monday, 09 July 2012